# Closed-Loop Glucagon Administration For Hypoglycemia Treatment

> **NCT02181127** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 31 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Glucagon-only Bionic Pancreas

## Key facts

- **NCT ID:** NCT02181127
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-06
- **Final completion:** 2017-04
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02181127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02181127, "Closed-Loop Glucagon Administration For Hypoglycemia Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02181127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*